0000950170-24-012894.txt : 20240208 0000950170-24-012894.hdr.sgml : 20240208 20240208171727 ACCESSION NUMBER: 0000950170-24-012894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231023 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESGEN LLC CENTRAL INDEX KEY: 0001865514 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40927 FILM NUMBER: 24610185 BUSINESS ADDRESS: STREET 1: 5956 SHERRY LANE, SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75225 BUSINESS PHONE: 214-987-6100 MAIL ADDRESS: STREET 1: 5956 SHERRY LANE, SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESGEN Acquisition Corp CENTRAL INDEX KEY: 0001865506 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 981601409 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5956 SHERRY LANE, SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75225 BUSINESS PHONE: 214-987-6100 MAIL ADDRESS: STREET 1: 5956 SHERRY LANE, SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75225 4 1 ownership.xml 4 X0508 4 2023-10-23 0001865506 ESGEN Acquisition Corp ESAC 0001865514 ESGEN LLC 5956 SHERRY LANE SUITE 1400 DALLAS TX 75225 false false true false false Class A Ordinary Shares 2023-10-23 4 C false 5619077 A 5619077 D Class B Ordinary Shares 2023-10-23 4 C false 5619077 D Class A Ordinary Shares 5619077 0 D As described in the Issuer's registration statement on Form S-1 (File No. 333-259836) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001 per share, will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. (continued from footnote 1) At an extraordinary general meeting of the Issuer's shareholders held on October 20, 2023, among other things, the Issuer's Amended and Restated Memorandum and Articles of Association was amended to change certain provisions which restrict the Class B ordinary shares from converting to Class A ordinary shares prior to the consummation of an initial business combination (the "Conversion Amendment"). In connection with the approval of the Conversion Amendment at the meeting, the Reporting Person converted all of its 5,619,077 Class B ordinary shares into an equal number of Class A ordinary shares. /s/ Andrejka Bernatova, as attorney-in-fact 2024-02-08